小青龙汤加减治疗慢性阻塞性肺病急性加重的临床效果(4)
[7]胡曉冬，顾培洁.益气补肾化痰祛瘀法在改善缓解期慢性阻塞性肺疾病合并肺心病患者生存质量中的应用[J].湖北中医药大学学报，2015，9(4)：55-57.
[8]Guo S，Sun Z，Liu E，et al.Effect of bufei granule on stable chronic obstructive pulmonary disease：a randomized，double blinded，placebo-controlled，and multicenter clinical study[J].J Tradit Chin Med，2014，34(4)：437-444.
[9]黄裕成，欧阳北江生，王喜琴，等.益气补肾化痰祛瘀法治疗缓解期慢阻肺并肺心病60例[J].江西中医药，2011，42(3)：22-23.
[10]Wang YJ，He LQ，Sun W，et al.Optimized project of traditional Chinese medicine in treating chronic kidney disease stage 3：a multicenter double-blinded randomized controlled trial[J].J Ethnopharmacol，2012，139(3)：757-764.
[11]张芸，高庆梅，张梅勇.通腑肃肺汤治疗慢性阻塞性肺疾病急性加重期30例临床观察[J].湖南中医杂志，2015，31(11)：63-65.
[12]Chen L，Chen G，Zhang MQ，et al.Imbalance between subsets of CD8(+)peripheral blood T cells in patients with chronic obstructive pulmonary disease[J].PeerJ，2016，4：e2301.
[13]杨志富，李梓.小青龙汤加减治疗嗜酸粒细胞性支气管炎临床疗效及对效应细胞、炎症介质的影响[J].浙江中西医结合杂志，2016，26(4)：331-334.
[14]Xu N，Chen J，Chang X，et al.nCD64 index as a prognostic biomarker for mortality in acute exacerbation of chronic obstructive pulmonary disease[J].Ann Saudi Med，2016，36(1)：37-41.
[15]高志妹，陈磊，王真.小青龙汤加味治疗咳嗽变异性哮喘(寒咳型)患儿的临床疗效研究[J].中医药学报，2016，44(4)：115-117.
[16]Depp TB，McGinnis KA，Kraemer K，et al.Risk factors associated with acute exacerbation of chronic obstructive pulmonary disease in HIV-infected and uninfected patients[J].AIDS，2016，30(3)：455-463.
[17]He H，Wang Y，Wu M，et al.Positive Epstein-Barr virus detection and mortality in respiratory failure patients admitted to the intensive care unit[J].Clin Respir J，2015，10(10)：12433-12439.
[18]Jia Z，Feng Z，Tian R，et al.Thymosin α1 plus routine treatment inhibit inflammatory reaction and improve the quality of life in AECOPD patients[J].Immunopharmacol Immunotoxicol，2015，37(4)：388-392., 百拇医药(李国梁)
[8]Guo S，Sun Z，Liu E，et al.Effect of bufei granule on stable chronic obstructive pulmonary disease：a randomized，double blinded，placebo-controlled，and multicenter clinical study[J].J Tradit Chin Med，2014，34(4)：437-444.
[9]黄裕成，欧阳北江生，王喜琴，等.益气补肾化痰祛瘀法治疗缓解期慢阻肺并肺心病60例[J].江西中医药，2011，42(3)：22-23.
[10]Wang YJ，He LQ，Sun W，et al.Optimized project of traditional Chinese medicine in treating chronic kidney disease stage 3：a multicenter double-blinded randomized controlled trial[J].J Ethnopharmacol，2012，139(3)：757-764.
[11]张芸，高庆梅，张梅勇.通腑肃肺汤治疗慢性阻塞性肺疾病急性加重期30例临床观察[J].湖南中医杂志，2015，31(11)：63-65.
[12]Chen L，Chen G，Zhang MQ，et al.Imbalance between subsets of CD8(+)peripheral blood T cells in patients with chronic obstructive pulmonary disease[J].PeerJ，2016，4：e2301.
[13]杨志富，李梓.小青龙汤加减治疗嗜酸粒细胞性支气管炎临床疗效及对效应细胞、炎症介质的影响[J].浙江中西医结合杂志，2016，26(4)：331-334.
[14]Xu N，Chen J，Chang X，et al.nCD64 index as a prognostic biomarker for mortality in acute exacerbation of chronic obstructive pulmonary disease[J].Ann Saudi Med，2016，36(1)：37-41.
[15]高志妹，陈磊，王真.小青龙汤加味治疗咳嗽变异性哮喘(寒咳型)患儿的临床疗效研究[J].中医药学报，2016，44(4)：115-117.
[16]Depp TB，McGinnis KA，Kraemer K，et al.Risk factors associated with acute exacerbation of chronic obstructive pulmonary disease in HIV-infected and uninfected patients[J].AIDS，2016，30(3)：455-463.
[17]He H，Wang Y，Wu M，et al.Positive Epstein-Barr virus detection and mortality in respiratory failure patients admitted to the intensive care unit[J].Clin Respir J，2015，10(10)：12433-12439.
[18]Jia Z，Feng Z，Tian R，et al.Thymosin α1 plus routine treatment inhibit inflammatory reaction and improve the quality of life in AECOPD patients[J].Immunopharmacol Immunotoxicol，2015，37(4)：388-392., 百拇医药(李国梁)